| Name | Terlipressin |
|---|---|
| Synonyms |
H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 acetate salt (Disulfide bond)
Triglycyl-8-lysine-vasopressin Terlipressin Diacetate Salt Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (disulfide bridge 4:9) Terlipressin Acetate Vasopressin, N-(glycylglycylglycyl)-8-L-lysine Gly-Gly-Gly-[Lys8]vasopressin N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin L-α-amino-n-Butyric acid (2S)-1-[(4S,7S,10S,13S,16S,19S)-19-[[2-[[2-[(2-Aminoacetyl)amino]acetyl]amino]acetyl]amino]-13-benzyl-10-(2-cbamoylethyl)-7-(cbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(1S)-5-amino-1-(cbamoylmethylcbamoyl)pentyl]pyrrolidine-2-cboxamide Glypressin N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin /Terlipressin Acetate Terlipressin for NMR identification Terlipressin(net) Thymosin α1 Acetate 14-5 Terlipressin-15NC6 Gly-Gly-Gly-L-Cys(1)-L-Tyr-L-Phe-L-Gln-L-Asn-L-Cys-L-Pro-L-Lys-Gly-NH2 MFCD00155450 Terlipressin Acetate salt Terlipressin CRS 1-Triglycyl-8-lysine Vasopressin N-(GLYCYLGLYCYLGLYCYL)-8-L-LYSINE-VASOPRESSIN (2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-{[({[(Aminoacetyl)amino]acetyl}amino)acetyl]amino}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-N-{(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxo-2-hexanyl}-2-pyrrolidinecarboxamide Nα-Glycylglycylglycyl-vasopressin EINECS 238-680-8 TERLIPRESSIN N-α-Triglycyl-8-lysine]-vasopressin TerlipressinuM Glycylpressin TERLIPRESSIN ACETATE Terilipressin Terlipressin acetate, >= H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH(Disulfide bond) Thymosin al Acetate Nα-Glycyl-glycyl-glycyl-lysine-vasopressin H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 TerlipressinuM Glycylpressin (2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-{[({[(Aminoacetyl)amino]acetyl}amino)acetyl]amino}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-N-{(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl}pyrrolidine-2-carboxamide (non-preferred name) Nα-Gly-Gly-Gly-8-Lys-vasopressin (2S)-N-[6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-7-(2-amino-2-oxoethyl)-19-[[2-[[2-[(2-amino-1-oxoethyl)amino]-1-oxoethyl]amino]-1-oxoethyl]amino]-10-(3-amino Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 TerlipressinQ: What is Terlipressin Q: What is the CAS Number of Terlipressin Q: What is the storage condition of Terlipressin Q: What e the applications of Terlipressin [N-α-Triglycyl-8-lysine]-vasopressin Nα-Glycyl-glycyl-glycyl-[8-lysine]-vasopressin N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin //BP 130: PN: WO2010033207 SEQID: 171 claiMed protein L-Cys(1)-L-Tyr-L-Phe-L-Gln-L-Asn-L-Cys-L-Pro-L-Lys-Gly-N-(Gly-Gly-Gly-)-NH2 Terlipressin, Terlipressine, Terlipressina, Terlipressinum |
| Description | Terlipressin is a potent vasoconstrictor that acts via V1 receptors on arteriolar smooth muscle cells. Terlipressin can result in splanchnic vasoconstriction augmenting systemic arterial blood pressure with beneficial circulatory and renal effects that would be expected to also ameliorate the key pathophysiological changes responsible for the development of refractory ascites |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 1824.0±65.0 °C at 760 mmHg |
| Molecular Formula | C52H74N16O15S2 |
| Molecular Weight | 1227.372 |
| Flash Point | 1056.9±34.3 °C |
| Exact Mass | 1226.496094 |
| PSA | 563.45000 |
| LogP | -6.75 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.664 |
| Storage condition | -20°C |